Comparison of Clinical Outcomes of Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.

被引：0
|
作者：
Wen, X. [1 ]
Casey, M. [1 ]
Santos, A. [1 ]
Hartzema, A. [2 ]
Womer, K. [1 ]
机构：
[1] Univ Florida, Dept Med, Gainesville, FL USA
[2] Univ Florida, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
289
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [21] A Comparison of Mycophenolate Mofetil With Mycophenolate Sodium in Renal Transplant Recipients on Tacrolimus-Based Treatment
    Aptaramanov, B.
    Seyahi, N.
    Alagoz, S.
    Pekmezci, S.
    Ataman, R.
    Tasci, H.
    Serdengecti, K.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 833 - 836
  • [22] A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up
    Foroncewicz, Bartosz
    Mucha, Krzysztof
    Ciszek, Michal
    Malkowski, Piotr
    Durlik, Magdalena
    Szmidt, Jacek
    Chmura, Andrzej
    Paczek, Leszek
    ANNALS OF TRANSPLANTATION, 2013, 18 : 384 - 392
  • [23] Comparable renal function in living kidney donors and their recipients on tacrolimus-based immunosuppression
    van Duijnhoven, EM
    Dackus, HJA
    Christiaans, MHL
    van Hooff, JP
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 489 - 489
  • [24] Primary tacrolimus-based immunosuppression in renal allograft recipients: A single center experience
    Lye, WC
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1700 - 1701
  • [25] Use of Basiliximab Induction in Low-Immunological Risk Renal Transplant Recipients Receiving Tacrolimus-Based Immunosuppression
    Gavela Martinez, E.
    Avila Bernabeu, A. I.
    Sancho Calabuig, A.
    Beltran Catalan, S.
    Escudero Quesada, V.
    Pallardo Mateu, L. M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2337 - 2338
  • [26] Tacrolimus-based immunosuppression in pediatric renal transplantation
    Jordan, ML
    Shapiro, R
    Scantlebury, V
    Vivas, C
    Ellis, D
    Lombardozzi-Lane, S
    Starzl, TE
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (7A) : 29S - 30S
  • [27] Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression
    Ueno, T.
    Kato, T.
    Gaynor, J.
    Velasco, M.
    Selvaggi, G.
    Nishida, S.
    Moon, J.
    Levi, D.
    Madariaga, J.
    Tzakis, A.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (06) : 1762 - 1764
  • [28] Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.
    Corman, SL
    Coley, KC
    Schonder, KE
    PHARMACOTHERAPY, 2005, 25 (03): : 475 - 475
  • [29] Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression
    Basu, Amit
    Falcone, John
    Dvorchik, Igor
    Tan, Henkie P.
    Schonder, Kristine
    Marsh, J. Wallis
    Zeevi, Adriana
    Humar, Abhinav
    Shapiro, Ron
    ANNALS OF TRANSPLANTATION, 2011, 16 (03) : 5 - 13
  • [30] Influence of Induction Therapy Using Basiliximab With Delayed Tacrolimus Administration in Heart Transplant Recipients - Comparison With Standard Tacrolimus-Based Triple Immunosuppression -
    Watanabe, Takuya
    Yanase, Masanobu
    Seguchi, Osamu
    Fujita, Tomoyuki
    Hamasaki, Toshimitsu
    Nakajima, Seiko
    Kuroda, Kensuke
    Kumai, Yuto
    Toda, Koichi
    Iwasaki, Keiichiro
    Kimura, Yuki
    Mochizuki, Hiroki
    Anegawa, Eiji
    Sujino, Yasumori
    Yagi, Nobuichiro
    Yoshitake, Koichi
    Wada, Kyoichi
    Matsuda, Sachi
    Takenaka, Hiromi
    Ikura, Megumi
    Nakagita, Kazuki
    Yajima, Shin
    Matsumoto, Yorihiko
    Tadokoro, Naoki
    Kakuta, Takashi
    Fukushima, Satsuki
    Ishibashi-Ueda, Hatsue
    Kobayashi, Junjiro
    Fukushima, Norihide
    CIRCULATION JOURNAL, 2020, 84 (12) : 2212 - 2223
12345